Clinical & Experimental Ophthalmology

Which way forward for treatment of severe ocular inflammation?
pp. 293-294(2)

Prophylaxis for pseudophakic cystoid macular oedema: a long way to go
pp. 295-296(2)

Eye care provision in the developing world: a regional perspective
pp. 297-298(2)

Use of a cyclo-oxygenase 2 inhibitor for prophylaxis of cystoid macular oedema following cataract surgery: a randomized placebo-controlled trial
pp. 299-304(6)
Authors: Riley, Andrew F; Wakely, Laura A; Patel, Hussain Y; Neveldsen, Bridget; Purdie, Gordon L; Wells, Anthony P

Is elevated level of soluble endothelial protein C receptor a new risk factor for retinal vein occlusion?
pp. 305-311(7)
Authors: Gumus, Koray; Kadayifcilar, Sibel; Eldem, Bora; Saracbası, Osman; Ozcebe, Osman; Dundar, Semra; Kirazli, Serafettin

Use of real-time telemedicine in the detection of diabetic macular oedema: a pilot study
pp. 312-316(5)
Authors: Peter, Jayanthi; Piantadosi, Julia; Piantadosi, Cynthia; Cooper, Peter; Gehling, Neil; Kaufmann, Claude; Goggin, Michael

Socioeconomic and rural differences for cataract surgery in Western Australia
pp. 317-323(7)
Authors: Ng, Jonathon Q; Morlet, Nigel; Semmens, James B

Aboriginal versus non-Aboriginal ophthalmic disease: admission characteristics at the Royal Adelaide Hospital
pp. 324-328(5)
Authors: Laforest, Caroline; Durkin, Shane; Selva, Dinesh; Casson, Robert; Newland, Henry

Prevalence of trachoma and diabetes-related eye disease among a cohort of adult Aboriginal patients screened over the period 1999–2004 in remote South Australia
pp. 329-334(6)
Authors: Durkin, Shane R; Casson, Robert; Newland, Henry S; Selva, Dinesh

Blindness and vision impairment in the elderly of Papua New Guinea
pp. 335-341(7)
Authors: Garap, Jambi N; Sheeladevi, Sethu; Shamanna, BR; Nirmalan, Praveen K; Brian, Garry; Williams, Carmel

Delayed ocular complications of mustard gas poisoning and the relationship with respiratory and cutaneous complications
pp. 342-346(5)
Authors: Etezad-Razavi, Mohammad; Mahmoudi, Mahmoud; Hefazi, Mehrdad; Balali-Mood, Mahdi

Cyclosporin A inhibits eosinophilic infiltration into the conjunctiva mediated by type IV allergic reactions
pp. 347-353(7)
Authors: Fukushima, Atsuki; Yamaguchi, Tomoko; Ishida, Waka; Fukata, Kazuyo; Liu, Fu-Tong; Ueno, Hisayuki

Magnetic resonance imaging assessment of fibrovascular ingrowth into porous polyethylene orbital implants
pp. 354-359(6)
Authors: Choi, Hee Young; Lee, Jong Soo; Park, Hyun Jun; Oum, Boo Sup; Kim, Hak Jin; Park, Do Youn

Encapsulated triamcinolone cyst after subtenon injection
pp. 360-362(3)
Authors: Chan, Carmen KM; Mohamed, Shaheeda; Tang, Emily WH; Shanmugam, Mahesh P; Chan, Nongnart R; Lam, Dennis SC

Retinal branch artery occlusion following injection of hyaluronic acid (Restylane)
pp. 363-364(2)
Authors: Peter, Silvia; Mennel, Stefan

Biologic therapies for inflammatory eye disease
pp. 365-374(10)
Authors: Lim, Lyndell; Suhler, Eric B; Smith, Justine R

Interferon α 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C
pp. 375-377(3)

Complicated hyphaema: think sickle
pp. 377-378(2)

Perforating ocular injury by Taser
pp. 378-380(3)

Acute retinal necrosis post intravitreal injection of triamcinolone acetonide
pp. 380-382(3)

Towards standards of outcome quality: a protocol for the surgical treatment of cataract in developing countries
pp. 383-387(5)

50-year-old transplants in the centenary year of corneal transplantation
pp. 387-388(2)

Intravitreous injections
pp. 388-390(3)

In vitro efficacy of cefazolin and povidone-iodine 5% in eradicating microbial organisms adhered to broad scleral buckles
pp. 390-391(2)

Continuing Professional Development
pp. 392-392(1)